Laura Evgin

Assistant Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Laura Evgin is an Assistant Professor at the University of British Columbia, Canada. Her research focuses on immunotherapy, particularly in the development and application of CAR T cell therapies and oncolytic viruses for cancer treatment. Recent articles include studies on minimally modified allogeneic CAR T cells and the role of oncolytic viruses in enhancing anti-tumor responses.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

Assistant Professor

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laura Evgin

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Minimally modified off-the-shelf allogeneic CAR T cells

Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response

Direct in vivo CAR T cell engineering

Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?

Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.

Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.

Oncolytic virus-derived type I interferon restricts CAR T cell therapy.

Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.

Collaborators (5)

Kristin G Anderson

Kelly Kersten

Rick Kennedy

Huy Dinh

Zinaida Good

Make your next move.